News Wire

129 POSTS 0 COMMENTS
Baby

Recruitment of Infants Begins for Phase 3 Trial of Cream to Reduce Risk of...

The trial needs 760 babies aged three weeks or younger whose parents or siblings suffer from either eczema, asthma or food allergies.
Eggs

Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy

AR201 is the second development program that Aimmune is advancing to phase 2 using its Characterized Oral Desensitization ImmunoTherapy (CODIT™) platform.
Teva Auto-Injectors

Teva Announces Availability of a Generic Equivalent of EpiPen Jr® Auto-Injector in the United...

The product is available at most retail pharmacies with a wholesale acquisition cost of $300 for a 2-pack.
Stressed Mom

Study: Food Allergies Are Top Concern for Families As They Prepare for Back-to-School

New Study Spotlights the Social, Emotional and Financial Impact of Managing Food Allergies
PSA

Watch: ‘Spell it Out’, A New Public Service Announcement About Food Allergies

PSA Stars Teen Actors Mace Coronel and Laya Hayes and Real Students with Food Allergies.
ANDIPen

Windgap Medical Announces Partnership with ALK-Abelló to Commercialize Novel “Wet/Dry” Epinephrine Auto-Injector

Novel auto-injector is designed to address many unmet patient needs like portability, temperature stability, ease-of-use, and long shelf-life.
Girl Eating

NIH Funds Kent State Psychologist’s Project to Teach Children Food Allergy Safety Skills

A Kent State University researcher with a background in safety training models has devised a method to help some children with food allergies stay safe.
Viaskin Patch

DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut for the Treatment...

This submission addresses the additional data needed on manufacturing procedures and quality controls which were communicated by the FDA in December.
T-Cell

Scientists Discover Immune Cell Subtype in Mice That Drives Allergic Reactions

NIH-funded study suggests targeting cell may help prevent anaphylaxis in humans.
Omalizumab + OIT

Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple Foods

NIH and partners to assess whether Omalizumab can reduce allergic reactions.

Connect with Us

39,156FansLike
779FollowersFollow
2,715FollowersFollow
5,528FollowersFollow
40SubscribersSubscribe